WallStreetZenWallStreetZen

NASDAQ: CYAN
Cyanotech Corp Stock

$1.02+0.03 (+3.03%)
Updated May 26, 2023
CYAN Price
$1.02
Fair Value Price
$1.44
Market Cap
$6.40M
52 Week Low
$0.82
52 Week High
$3.57
P/E
-3.52x
P/B
0.36x
P/S
0.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.91M
Earnings
-$1.73M
Gross Margin
33.8%
Operating Margin
-5.02%
Profit Margin
-6.7%
Debt to Equity
0.68
Operating Cash Flow
-$2M
Beta
0.14
Next Earnings
Jun 20, 2023
Ex-Dividend
N/A
Next Dividend
N/A

CYAN Overview

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

Zen Score

Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CYAN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CYAN ($1.02) is undervalued by 29.15% relative to our estimate of its Fair Value price of $1.44 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CYAN ($1.02) is significantly undervalued by 29.15% relative to our estimate of its Fair Value price of $1.44 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CYAN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CYAN due diligence checks available for Premium users.

Be the first to know about important CYAN news, forecast changes, insider trades & much more!

CYAN News

Valuation

CYAN fair value

Fair Value of CYAN stock based on Discounted Cash Flow (DCF)
Price
$1.02
Fair Value
$1.44
Undervalued by
29.15%
CYAN ($1.02) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CYAN ($1.02) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CYAN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CYAN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.52x
Industry
20.92x
Market
54.23x

CYAN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.36x
Industry
2.36x
CYAN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CYAN's financial health

Profit margin

Revenue
$5.9M
Net Income
-$598.0k
Profit Margin
-10.2%
CYAN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CYAN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$29.8M
Liabilities
$12.0M
Debt to equity
0.68
CYAN's short-term assets ($14.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CYAN's short-term assets ($14.53M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CYAN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CYAN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$223.0k
Investing
-$328.0k
Financing
$685.0k
CYAN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CYAN vs Food Stocks

TickerMarket Cap1d %P/EP/B
CYAN$6.40M+3.24%-3.52x0.36x
BTOG$6.74M-4.29%0.15x0.20x
BON$5.86M+6.08%0.93x0.20x
LSF$7.27M-8.54%-0.23x0.39x
RIBT$5.00M-10.11%-0.54x0.45x

Cyanotech Stock FAQ

What is Cyanotech's quote symbol?

(NASDAQ: CYAN) Cyanotech trades on the NASDAQ under the ticker symbol CYAN. Cyanotech stock quotes can also be displayed as NASDAQ: CYAN.

If you're new to stock investing, here's how to buy Cyanotech stock.

What is the 52 week high and low for Cyanotech (NASDAQ: CYAN)?

(NASDAQ: CYAN) Cyanotech's 52-week high was $3.57, and its 52-week low was $0.82. It is currently -71.46% from its 52-week high and 24.39% from its 52-week low.

How much is Cyanotech stock worth today?

(NASDAQ: CYAN) Cyanotech currently has 6,271,971 outstanding shares. With Cyanotech stock trading at $1.02 per share, the total value of Cyanotech stock (market capitalization) is $6.40M.

Cyanotech stock was originally listed at a price of $11.12 in Dec 31, 1997. If you had invested in Cyanotech stock at $11.12, your return over the last 25 years would have been -90.83%, for an annualized return of -9.11% (not including any dividends or dividend reinvestments).

How much is Cyanotech's stock price per share?

(NASDAQ: CYAN) Cyanotech stock price per share is $1.02 today (as of May 26, 2023).

What is Cyanotech's Market Cap?

(NASDAQ: CYAN) Cyanotech's market cap is $6.40M, as of May 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cyanotech's market cap is calculated by multiplying CYAN's current stock price of $1.02 by CYAN's total outstanding shares of 6,271,971.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.